Web14 dec. 2024 · Jnana Therapeutics @jnanatx · Nov 2, 2024 We’re applying our RAPID platform to address hard-to-drug targets including SLC transporters, scaffold proteins, … Web15 nov. 2024 · Jnana Therapeutics is a clinical-stage biotechnology company leveraging its next-generation chemoproteomics RAPID platform to discover medicines for highly validated, challenging-to-drug targets...
Jnana Therapeutics Raises $107 Million to Advance Lead PKU …
WebFind company research, competitor information, contact details & financial data for Jnana Therapeutics Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet. Web3 feb. 2024 · Jnana uses its RAPID platform, a proprietary, cell-based drug discovery approach, to systematically target SLC transporters and develop best-in-class therapies … red beach newcastle
Shelby Brantley - Senior Scientist I - Jnana Therapeutics …
Web21 jul. 2024 · Jnana Therapeutics Enters Collaboration with Roche to Discover Novel Medicines that Target Key Regulators of Cellular Metabolism to Treat Immune-Mediated … Web15 nov. 2024 · BOSTON, Nov. 15, 2024 /PRNewswire/ -- Jnana Therapeutics ("Jnana"), a biotechnology company leveraging its next-generation chemoproteomics platform to … Web16 nov. 2024 · Jnana Therapeutics and Roche have signed a second partnership and licence agreement to discover small-molecule drugs to treat cancer, immune-mediated and neurological ailments. The deal covers multiple targets from a varying range of target classes for addressing ailments with high unmet needs. red beach okinawa